Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03747120 |
| Title | Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Cedars-Sinai Medical Center |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Cedars Sinai Medical Center | Los Angeles | California | 90048 | United States | Details | |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States | Details | |
| New Mexico Cancer Center | Albuquerque | New Mexico | 87109 | United States | Details | |
| Providence Cancer Institute | Portland | Oregon | 97213 | United States | Details | |
| UT Southwestern Medical Center | Dallas | Texas | 75006-7541 | United States | Details |